Published on: March 12, 2018
by Sandee LaMott for CNN:
Poor sleep and the risk of dementia go hand in hand, but no one knew which came first. In what researchers say is the first study of its kind, a study published Monday in the journal JAMA Neurology shows that excessive daytime sleepiness in cognitively normal elderly leads to a buildup of a plaque in the brain called amyloid.
Depositing amyloid in brain tissue is the first known preclinical stage of Alzheimer’s and happens well before any obvious symptoms of dementia begin.
“We know that sleep is necessary to clear toxins and beta-amyloid in the brain,” said study author Prashanthi Vemuri, a research faculty member at the Mayo Clinic, where the study was done. “We also know that beta-amyloid causes sleep disruptions. So, it’s been a chicken and an egg problem.
“In our study, we wanted to know if excessive daytime sleepiness causes an increase of amyloid over time in people without dementia,” Vemuri continued. “And the answer was yes.”
“While further research is necessary, this study adds a new question that doctors can ask patients to assess risk and potentially intervene, said Dr. Richard Isaacson, Director of the Alzheimer’s Prevention Clinic at Weill Cornell Medicine and NewYork-Presbyterian, who was not involved in the study.
“In fact, the findings will change the way i care for patients,” said Isaacson, “as i will now proactively ask about excessive daytime sleepiness as one of the many potentially modifiable risk factors for the disease.”
The Mayo researchers reached out to people 70 and older who were enrolled in the Mayo Clinic Study of Aging, a population-based sample in Olmsted County, Minnesota. To be included in the study, participants had to have baseline scan and a later scan of their brains on file, complete a sleep quality questionnaire and be certified free of dementia by a team of specialists who administered a battery of cognitive tests.
That process whittled down the initial sample of 2,172 to 283 people with an average age of 77. Researchers measured the amount of beta-amyloid buildup in their brains over time, and compared those results to the amount of daytime sleepiness each person reported.
Subjects who were most drowsy during the day were found to have greater amounts of Alzheimer’s-causing amyloids over the two-year period of the study, especially in the areas of the brain responsible for emotion, memory retrieval and behavior.
In an editorial that accompanied the study, sleep researchers Bryce Mander of the University of California, Irvine and Joseph Winer of the University of California, Berkeley said the study was the first to directly addresses the relationship over time of poor sleep and biomarkers for developing Alzheimer’s.
“What we’re excited about is that it’s the first to show longitudinal evidence in humans,” Winer said in an interview. “Most of our evidence has come from mice studies and looking at people at one time point. This is the first study that followed people over time.”
Dr. Yo-El Ju, a neurologist at the Washington University School of Medicine, agreed. “Importantly, it is the first longitudinal study of the relationship between sleep and Alzheimer’s Disease in the preclinical stage, meaning before any cognitive changes appear,” said Ju. “This finding is important because it means we could potentially treat sleep problems to reduce risk of AD years down the road.” However, the study was not able to determine what type of sleep disruption — such as insomnia, obstructive sleep apnea or restless legs syndrome — was the cause of the daytime fatigue.
The study was not able to answer the role of sleep stages, the extent of the damage that poor sleep might cause, nor “the extent to which treatment of OSA (obstructive sleep apnea) or other disorders or increased sleep duration can slow down amyloid accumulation and cognitive decline,” said Dr. Eric Reiman, executive director of the Banner Alzheimer’s Institute, who was not involved in the study. He hopes future research will tackle those and other questions.
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.